Microbiological Analysis and Mortality Risk Factors in Patients with Polymicrobial Bloodstream Infections

References

• McNamara JF, Righi E, Wright H, Hartel GF, Harris PNA, Paterson DL. Long-term morbidity and mortality following bloodstream infection: a systematic literature review. J Infect. 2018;77(1):1–8. doi:10.1016/j.jinf.2018.03.005
   PubMed Web of Science ®Google Scholar
• Lin H, Yang L, Fang J, et al. Clinical characteristics of bloodstream infection in immunosuppressed patients: a 5-year retrospective cohort study. Front Cell Infect Microbiol. 2022;12:796656. doi:10.3389/fcimb.2022.796656
   PubMed Web of Science ®Google Scholar
• Gerver SM, Mihalkova M, Bion JF, et al. Surveillance of bloodstream infections in intensive care units in England, May 2016–April 2017: epidemiology and ecology. J Hosp Infect. 2020;106(1):1–9. doi:10.1016/j.jhin.2020.05.010
   PubMed Web of Science ®Google Scholar
• Pavlaki M, Poulakou G, Drimousis P, et al. Polymicrobial bloodstream infections: epidemiology and impact on mortality. J Glob Antimicrob Resist. 2013;1(4):207–212. doi:10.1016/j.jgar.2013.06.005
   PubMed Web of Science ®Google Scholar
• Chen Q, Zheng Z, Shi Q, Wu H, Li Y, Zheng C. Multidrug-resistant Acinetobacter baumannii may cause patients to develop polymicrobial bloodstream infection. Can J Infect Dis Med Microbiol. 2022;2022:8368578. doi:10.1155/2022/8368578
   PubMed Web of Science ®Google Scholar
• Kazlauskas E, Gegieckaite G, Eimontas J, Zelviene P, Maercker A. A brief measure of the international classification of diseases-11 adjustment disorder: investigation of psychometric properties in an adult help-seeking sample. Psychopathology. 2018;51(1):10–15. doi:10.1159/000484415
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552. doi:10.1097/CCM.0000000000002255
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Hsueh PR, Mendes RE, et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7). doi:10.1128/AAC.00355-19
   PubMed Web of Science ®Google Scholar
• Watanabe T, Hara Y, Yoshimi Y, et al. Application of MALDI-TOF MS to assess clinical characteristics, risk factors, and outcomes associated with anaerobic bloodstream infection: a retrospective observational study. Ann Clin Microbiol Antimicrob. 2021;20(1):42. doi:10.1186/s12941-021-00449-4
   PubMed Web of Science ®Google Scholar
• Di Bella S, Antonello RM, Sanson G, et al. Anaerobic bloodstream infections in Italy (ITANAEROBY): a 5-year retrospective nationwide survey. Anaerobe. 2022;75:102583. doi:10.1016/j.anaerobe.2022.102583
   PubMed Web of Science ®Google Scholar
• Rubin LG, Moxon ER. Pathogenesis of bloodstream invasion with Haemophilus influenzae type b. Infect Immun. 1983;41(1):280–284. doi:10.1128/iai.41.1.280-284.1983
   PubMedGoogle Scholar
• Chien YC, Huang YT, Liao CH, Chien JY, Hsueh PR. Clinical characteristics of bacteremia caused by Haemophilus and Aggregatibacter species and antimicrobial susceptibilities of the isolates. J Microbiol Immunol Infect. 2021;54(6):1130–1138. doi:10.1016/j.jmii.2020.12.002
   PubMedGoogle Scholar
• Hsiao YC, Lee YH, Ho CM, Tseng CH, Wang JH. Clinical characteristics of actinomyces viscosus bacteremia. Medicina. 2021;57(10):1064. doi:10.3390/medicina57101064
   PubMedGoogle Scholar
• Chiou CS, Liao YS, Chen BH, et al. Demographic features of invasive meningococcal disease in Taiwan, 1993 to 2020, and genetic characteristics of Neisseria meningitidis isolates, 2003 to 2020. Microbiol Spectr. 2022;10(4):e0088222. doi:10.1128/spectrum.00882-22
   PubMed Web of Science ®Google Scholar
• Melican K, Dumenil G. Vascular colonization by Neisseria meningitidis. Curr Opin Microbiol. 2012;15(1):50–56. doi:10.1016/j.mib.2011.10.008
   PubMed Web of Science ®Google Scholar
• Staudacher JJ, Wittenberg M, Schneider T. Bloodstream infection by Neisseria meningitidis. Dtsch Arztebl Int. 2022;119(33–34):557. doi:10.3238/arztebl.m2022.0156
   PubMed Web of Science ®Google Scholar
• Facchin G, Candoni A, Lazzarotto D, et al. Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey. Support Care Cancer. 2022;30(3):2359–2366. doi:10.1007/s00520-021-06640-9
   PubMed Web of Science ®Google Scholar
• Karakonstantis S, Kritsotakis EI. Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex. Infection. 2021;49(6):1149–1161. doi:10.1007/s15010-021-01663-0
   PubMed Web of Science ®Google Scholar
• Yo CH, Hsein YC, Wu YL, et al. Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection. Int J Antimicrob Agents. 2019;54(6):716–722. doi:10.1016/j.ijantimicag.2019.09.015
   PubMed Web of Science ®Google Scholar
• Claeys KC, Heil EL, Pogue JM, et al. The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision making. Diagn Microbiol Infect Dis. 2018;91(2):144–146. doi:10.1016/j.diagmicrobio.2018.01.012
   PubMed Web of Science ®Google Scholar
• Chen Y, Ji J, Ying C, et al. Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019. Antimicrob Resist Infect Control. 2022;11(1):17. doi:10.1186/s13756-022-01055-5
   PubMed Web of Science ®Google Scholar
• Timsit JF, Ruppé E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46(2):266–284. doi:10.1007/s00134-020-05950-6
   PubMed Web of Science ®Google Scholar
• Abe T, Ogura H, Shiraishi A, et al. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care. 2018;22(1):322. doi:10.1186/s13054-018-2186-7
   PubMedGoogle Scholar
• Yuan Y, Wang J, Yao Z, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infections and outcomes. Infect Drug Resist. 2020;13:207–215. doi:10.2147/IDR.S223243
   PubMed Web of Science ®Google Scholar
• Bulman ZP, Krapp F, Pincus NB, et al. Genomic features associated with the degree of phenotypic resistance to carbapenems in carbapenem-resistant Klebsiella pneumoniae. mSystems. 2021;6(5):e0019421. doi:10.1128/mSystems.00194-21
   PubMed Web of Science ®Google Scholar
• El Houssaini Z, Harrar N, Zerouali K, Belabbes H, Elmdaghri N. Prévalence des staphylocoques à coagulase négative dans les hémocultures au Centre Hospitalier Universitaire Ibn Rochd de Casablanca [Prevalence of coagulase-negative staphylococci in blood cultures at the Ibn-Rochd University Hospital in Casablanca]. Pan Afr Med J. 2019;33. French. doi:10.11604/pamj.2019.33.193.18552
   Google Scholar
• Asai N, Sakanashi D, Suematsu H, et al. Clinical characteristics and relevance of coagulase-negative Staphylococci other than S epidermidis by positive blood culture. J Microbiol Immunol Infect. 2021;54(4):632–638. doi:10.1016/j.jmii.2020.03.001
   PubMedGoogle Scholar
• Almeida Junior ER, Braga IA, Filho PPG, Ribas RM. Multicentre surveillance of epidemiologically important pathogens causing nosocomial bloodstream infections and pneumonia trials in Brazilian adult intensive care units. J Med Microbiol. 2023;72(2). doi:10.1099/jmm.0.001654
   PubMed Web of Science ®Google Scholar
• Pouget C, Chatre C, Lavigne JP, Pantel A, Reynes J, Dunyach-Remy C. Effect of antibiotic exposure on Staphylococcus epidermidis responsible for catheter-related bacteremia. Int J Mol Sci. 2023;24(2):1547. doi:10.3390/ijms24021547
   PubMed Web of Science ®Google Scholar
• Bekhit OE, Yousef RM, Abdelrasol HA, Mohammed MA. Serum albumin level as a predictor of outcome in patients admitted to pediatric intensive care units. Pediatr Emerg Care. 2021;37(12):e855–e860. doi:10.1097/PEC.0000000000002567
   PubMed Web of Science ®Google Scholar
• Shannon CM, Ballew SH, Daya N, et al. Serum albumin and risks of hospitalization and death: findings from the atherosclerosis risk in communities study. J Am Geriatr Soc. 2021;69(10):2865–2876. doi:10.1111/jgs.17313
   PubMed Web of Science ®Google Scholar
• Hu F, Yuan L, Yang Y, et al. A multicenter investigation of 2773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET). Front Cell Infect Microbiol. 2022;12:1075185. doi:10.3389/fcimb.2022.1075185
   PubMed Web of Science ®Google Scholar
• Giannella M, Pascale R, Ferraro G, et al. Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: a retrospective, single-centre, cohort study. Int J Antimicrob Agents. 2019;53(5):574–581. doi:10.1016/j.ijantimicag.2019.01.005
   PubMed Web of Science ®Google Scholar
• Ju M, Huang Y, Xu X, et al. Predictors of mortality in adult patients with methicillin-resistant Staphylococcus aureus bloodstream infection: a meta-analysis and systematic review. Ann Palliat Med. 2021;10(8):8617–8627. doi:10.21037/apm-21-932
   PubMed Web of Science ®Google Scholar
• Song F, Zhang K, Huang J, et al. Clinical characteristics, risk factors, and outcomes of patients with polymicrobial Klebsiella pneumoniae bloodstream infections. Biomed Res Int. 2021;2021:6619911. doi:10.1155/2021/6619911
   PubMed Web of Science ®Google Scholar